Literature DB >> 7894209

Comparison of serum phospholipase A2, polymorphonuclear granulocyte elastase, C-reactive protein and serum amyloid A with the APACHE II score in the prognosis of multiple injured patients.

R Ensenauer1, M Püttmann, M Quintel, R Kattermann, J Aufenanger.   

Abstract

This prospective study of 35 multitraumatized intensive care unit patients requiring mechanical ventilation examined the relative utility of four biochemical parameters with a physiological scoring system for predicting lethal outcome. Levels of serum phospholipase A2 (PLA2), serum amyloid A (SAA), polymorphonuclear granulocyte elastase (PMN elastase), and C-reactive protein (CRP) were determined at short intervals during the patient's hospitalization. The first specimen was obtained at the time of admission, and subsequent specimens were drawn at 8 h intervals for the first 48 h and then twice daily until death or convalescence. Calculations of the APACHE II score used the most deranged variables during the first 24 h of admission to assess patient outcome. Additional calculations of the APACHE II score at the time of each blood draw served as an indicator of patient status. The results indicate that during the first 24 h after admission none of the four examined biochemical parameters gives reliable information about the outcome. The APACHE II score provided the earliest indicator of patient outcome (83% sensitivity, 65% specificity). PMN elastase provided useful information first at 32 h (83% sensitivity, 45% specificity) and better at 132 h (86% sensitivity, 86% specificity). CRP was of intermediate use in predicting outcome initially at 72 h (83% sensitivity, 50% specificity) and later at 132 h (86% sensitivity, 93% specificity). PLA2 and SAA were not useful as early indicators of lethal outcome.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7894209     DOI: 10.1007/bf00190738

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  23 in total

Review 1.  [Scoring systems in the surgical intensive care unit. I].

Authors:  C Ohmann; W Gross-Weege
Journal:  Chirurg       Date:  1992-12       Impact factor: 0.955

2.  [Trauma scores: reproducibility and reliability].

Authors:  C Waydhas; D Nast-Kolb; A Trupka; C Kerim-Sade; G Kanz; J Zoller; L Schweiberer
Journal:  Unfallchirurg       Date:  1992-02       Impact factor: 1.000

Review 3.  Chemistry with confidence: should Clinical Chemistry require confidence intervals for analytical and other data?

Authors:  A R Henderson
Journal:  Clin Chem       Date:  1993-06       Impact factor: 8.327

4.  [Criteria for the operability of patients with multiple injuries (author's transl)].

Authors:  O Trentz; H J Oestern; G Hempelmann; H Kolbow; J Sturm; O A Trentz; H Tscherne
Journal:  Unfallheilkunde       Date:  1978-06

5.  Serum markers of immune activation and liver allograft rejection.

Authors:  E Lalli; R Meliconi; R Conte; A Mancini; M Uguccioni; G F Stefanini; G Gasbarrini
Journal:  Dig Dis Sci       Date:  1992-07       Impact factor: 3.199

6.  Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response.

Authors:  R M Crowl; T J Stoller; R R Conroy; C R Stoner
Journal:  J Biol Chem       Date:  1991-02-05       Impact factor: 5.157

7.  Prognostic value of serum phospholipase A in the multitraumatized patient.

Authors:  C Waydhas; D Nast-Kolb; K H Duswald; P Lehnert; L Schweiberer
Journal:  Klin Wochenschr       Date:  1989-02-01

8.  Serum activities of phospholipase A in acute posttraumatic pulmonary insufficiency.

Authors:  R Koeniger; G E Hoffmann; T O Schmid
Journal:  Klin Wochenschr       Date:  1989-02-01

9.  Posttraumatic complications and inflammatory mediators.

Authors:  J K Nuytinck; J A Goris; H Redl; G Schlag; P J van Munster
Journal:  Arch Surg       Date:  1986-08

10.  Acute phase protein response to tissue injury.

Authors:  W M Stahl
Journal:  Crit Care Med       Date:  1987-06       Impact factor: 7.598

View more
  1 in total

Review 1.  Immune depression in musculoskeletal trauma.

Authors:  Olav Reikerås
Journal:  Inflamm Res       Date:  2010-02-11       Impact factor: 4.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.